Abstract
Polymorphous light eruption (PLE) is one of the acquired idiopathic photodermatosis mainly induced by immoderate UV radiation. In order to realize UV protection and medicine administration simultaneously for polymorphous light eruption protection and therapy, Acetyl-11-keto-β-boswellic acid (AKBA) loaded Zinc Oxide (ZnO) nanoparticles of which drug release behavior is UV-controlled has been successfully synthesized. Such nanoparticles can not only reflect UV but also transfer the energy to release AKBA which presents an excellent antioxidant and anti-inflammatory effects. In addition, they are biocompatible to HaCaT cells. As a result, they have a great potential in combining UV protection and medicine administration simultaneously for PLE protection and therapy.
Keywords:
AKBA; PLE; Prevention and treatment integrated; UV radiation; ZnO.
Copyright © 2019 Elsevier B.V. All rights reserved.
MeSH terms
-
Anti-Inflammatory Agents / chemistry
-
Anti-Inflammatory Agents / metabolism
-
Anti-Inflammatory Agents / pharmacology
-
Antioxidants / chemistry
-
Biocompatible Materials / chemistry
-
Biocompatible Materials / metabolism
-
Biocompatible Materials / pharmacology
-
Cell Line
-
Cell Survival / drug effects
-
Cyclooxygenase 2 / genetics
-
Cyclooxygenase 2 / metabolism
-
Drug Liberation
-
Humans
-
Keratinocytes / cytology
-
Keratinocytes / drug effects
-
Keratinocytes / metabolism
-
Nanoparticles / chemistry*
-
Nanoparticles / toxicity
-
Photosensitivity Disorders / pathology
-
Photosensitivity Disorders / prevention & control
-
Reactive Oxygen Species
-
Triterpenes / chemistry*
-
Triterpenes / metabolism
-
Triterpenes / pharmacology
-
Ultraviolet Rays*
-
Zinc Oxide / chemistry*
Substances
-
Anti-Inflammatory Agents
-
Antioxidants
-
Biocompatible Materials
-
Reactive Oxygen Species
-
Triterpenes
-
acetyl-11-ketoboswellic acid
-
Cyclooxygenase 2
-
Zinc Oxide